Drugs Cheaper Than Threepenny: The Market of Extremely Low-Priced Drugs within the National Health Insurance in Taiwan

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="234941.fig.002a" src="https://static.hindawi.com/articles/tswj/volume-2014/234941/figures/234941.fig.002a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>Market share</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="234941.fig.002b" src="https://static.hindawi.com/articles/tswj/volume-2014/234941/figures/234941.fig.002b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Cumulative market share</td></tr></table></td></tr></table>

<table>Market share of oral pills (tablets and capsules) prescribed within Taiwan’s National Health Insurance in 2007. (a) Market share. (b) Cumulative market share.</table>

The Scientific World Journal

fig2

Figure 2

Figure 2: Drugs Cheaper Than Threepenny: The Market of Extremely Low-Priced Drugs within the National Health Insurance in Taiwan 